New insider activity at Exelixis ( (EXEL) ) has taken place on May 22, 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Exelixis has seen notable insider activity as EVP, Commercial Patrick J. Haley executed a significant stock sale, offloading 32,110 shares of the company’s stock. The transaction, valued at $1,599,399, highlights a sizable move by a key executive within the organization.
Recent Updates on EXEL stock
Exelixis shares reacted to its Q1 call, where strong CABOMETYX revenue growth, solid profitability, and a $1.4B cash position supported sentiment, but higher gross‑to‑net discounts and a sharply larger tax provision highlighted margin and earnings volatility. Analysts also weighed expanding ZANZA pivotal programs and new meningioma and RCC trials as long‑term growth drivers, while stressing that reliance on multiple high‑risk late‑stage readouts and partner‑run studies could justify reassessing valuation assumptions and risk premia over the near term.
Spark’s Take on EXEL Stock
According to Spark, TipRanks’ AI Analyst, EXEL is a Outperform.
EXEL scores highly due to strong financial performance (very high margins, excellent cash conversion, and low leverage) and a supportive earnings-call backdrop (reiterated guidance, strong CABOMETYX momentum, and significant buybacks). Technicals are constructive with price above key moving averages and positive momentum. Valuation is reasonable on P/E, though the lack of a dividend yield limits that component’s upside.
To see Spark’s full report on EXEL stock, click here.
More about Exelixis
YTD Price Performance: 13.28%
Average Trading Volume: 2,795,035
Technical Sentiment Signal: Buy
Current Market Cap: $12.54B